Guizhou Hongyu Pharmaceutical Co., Ltd. is a key enterprise in Guiyang National High-tech Industrial Development Zone. The Guizhou Provincial Science and Technology Commission has identified as a "high-tech enterprise" as a backbone enterprise in the pharmaceutical industry in Guizhou Province. Since its establishment, the company has always positioned its development as a combination of Guizhou's authentic Chinese medicinal materials resources with modern high-tech pharmaceutical technology. Dare to play Guizhou cards, be good at playing Guizhou cards, and effectively allocate resources. In recent years, the company's development has increased at a rate of 50%. In December 1999, with the approval of the Ministry of Foreign Trade and Economic Cooperation, the company was approved for self-operated import and export rights.

The company is located in Guiyang National High-tech Industrial Development Zone, covering an area of ​​29,000 square meters, with a construction area of ​​8,812.9 square meters, and has a production line of capsules, aerosols and granules. It is also equipped with high-performance liquid chromatographs, dual-wavelength flying point scanners, ultraviolet rays, and visible spectrophotometers and other advanced precision detection instruments produced by Shimadzu Manufacturing in Japan. Currently, the company's main products on the market include "Qianli Gastrodia eucommia ulmoides capsules", "Jinhujian spray", "Baofukang foam agent", and "Single flavor Chinese medicine refined granule decoction". The product quality is stable and the efficacy is accurate. Among them: "Kenli Gastrodia eucommia ulmoides Capsules" and the new drug "Baofukang Foam" have entered the national basic medicine catalog, and "Kenli Gastrodia eucommia ulmoides Capsules" are listed as national traditional Chinese medicine protected varieties. "Baofukang Foaming Agent" was rated as a national key new product of the State Economic and Trade Commission in 1999. "3CT Technology Development Project for Single-flavor Chinese Medicine Refined Granules" is listed as a national high-tech industrialization promotion project. While further expanding the domestic market, the company actively explores foreign markets, raises funds through the capital market, accelerates the industrialization of high-tech achievements, continuously enhances the company's competitiveness, and strives to enter the ranks of advanced pharmaceutical companies in China.